Cargando…
HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
Hepatocyte growth factor (HGF) was discovered in 1984 as a mitogen of rat hepatocytes in a primary culture system. In the mid-1980s, MET was identified as an oncogenic mutant protein that induces malignant phenotypes in a human cell line. In the early 1990s, wild-type MET was shown to be a functiona...
Autores principales: | Mizuno, Shinya, Nakamura, Toshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565297/ https://www.ncbi.nlm.nih.gov/pubmed/23296269 http://dx.doi.org/10.3390/ijms14010888 |
Ejemplares similares
-
The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
por: NAKAMURA, Toshikazu, et al.
Publicado: (2010) -
HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014) -
Role of HGF/c‐Met in the treatment of colorectal cancer with liver metastasis
por: Yao, Jian‐feng, et al.
Publicado: (2019) -
Expression of HGF and Met in Human Tissues of Colorectal Cancers: Biological and Clinical Implications for Synchronous Liver Metastasis
por: Sun, Yan-lai, et al.
Publicado: (2013) -
Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
por: Kim, Hyun Jung
Publicado: (2022)